Key result
The SAPAAD study is a prospective, nonrandomized study designed to evaluate the diagnostic accuracy of a pacemaker algorithm for sleep apnea in 68 patients; no results are reported.
Why the study?
Does a novel pacemaker algorithm (RDI) accurately diagnose severe sleep apnea compared to AHI in patients with diastolic dysfunction requiring a pacemaker?
Observational (n=68)
No
Does a novel pacemaker algorithm (RDI) accurately diagnose severe sleep apnea compared to AHI in patients with diastolic dysfunction requiring a pacemaker?
This study design outlines a prospective evaluation of a novel pacemaker algorithm for diagnosing sleep apnea in patients with diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
Leaves open pacemaker RDI accuracy for sleep apnea diagnosis in diastolic dysfunction; validation trials needed before clinical use.
Previous studies showed good agreement between pacemaker respiratory disturbance index (RDI) and polysomnography for diagnosis of severe sleep apnea (SA). The aim of this study is to investigate the diagnostic accuracy of RDI compared with apnea-hypopnea index (AHI) from a cardiorespiratory sleep study for the diagnosis of severe SA within patients requiring a pacemaker and meeting diastolic dysfunction criteria. Secondary objectives are as follows: correlation between plasma aldosterone level and SA severity, diagnostic accuracy of RDI for moderate SA, prevalence of SA among patients with diastolic dysfunction, occurrence of arrhythmias, and improvement of RDI with continuous positive airway pressure therapy. We designed a monocentric prospective nonrandomized study of prevalent cases to include 68 patients with a 6-month follow-up. Both RDI and AHI will be compared 2 months after implantation and after 1 month of continuous positive airway pressure treatment in patients with severe SA. This is the first study that examines diagnostic accuracy of pacemaker algorithm for the diagnosis of SA and correlation with plasma aldosterone levels in patients with diastolic dysfunction. Protocol version: V04. 04/04/2017 Trial registration: ClinicalTrials.gov NCT02751021.
No takes yet. Share an insight, caveat, or question.
Champ‐Rigot et al. (2018) conducted an observational in Diastolic dysfunction and requiring a pacemaker (n=68). Pacemaker respiratory disturbance index (RDI) vs. Apnea-hypopnea index (AHI) from a cardiorespiratory sleep study was evaluated on Diagnostic accuracy of RDI compared with AHI for the diagnosis of severe sleep apnea. The SAPAAD study is a prospective, nonrandomized study designed to evaluate the diagnostic accuracy of a pacemaker algorithm for sleep apnea in 68 patients; no results are reported.
Synapse has enriched 10 related papers. Consider them for comparative context: